Ines Nevelsteen

5PUBLICATIONS
59CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Cancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jun 13, 2025
Association of HER2-low with clinicopathological features in patients with early invasive lobular breast cancer: an international multicentric study.

Karen Van Baelen, Ha-Linh Nguyen, François Richard

|Dec 26, 2023
Treatment Response, Tumor Infiltrating Lymphocytes and Clinical Outcomes in Inflammatory Breast Cancer-Treated with Neoadjuvant Systemic Therapy.

Maxim De Schepper, Ha-Linh Nguyen, François Richard

|Jan 20, 2021
Features of durable response and treatment efficacy for capecitabine monotherapy in advanced breast cancer: real-world evidence from a large single-centre cohort.

S Thijssen, H Wildiers, K Punie

|Nov 25, 2020
Breast cancer-related lymphedema and its treatment: how big is the financial impact?

Tessa De Vrieze, Nick Gebruers, Ines Nevelsteen

|Jul 14, 2020
Cancer Surveillance in Healthy Carriers of Germline Pathogenic Variants in <i>BRCA1/2</i>: A Review of Secondary Prevention Guidelines.

Boudewijn Dullens, Robin de Putter, Matteo Lambertini

Pageof 1

Frequent Collaborators

4 joint publications

Ann Smeets

3 joint publications

Hans Wildiers

3 joint publications

Kevin Punie

3 joint publications

Patrick Neven